Ultrasound vendors faced intense competition during the secondquarter of this year. Diasonics reported that pricing pressureskept its ultrasound business in the red for the second quarter(end-June). Ultrasound revenue remained at about the same levelas
Ultrasound vendors faced intense competition during the secondquarter of this year. Diasonics reported that pricing pressureskept its ultrasound business in the red for the second quarter(end-June). Ultrasound revenue remained at about the same levelas the first quarter of 1991, the vendor said.
Overall, however, Diasonics had a 17% jump in revenue, from$59.5 million in the second quarter of 1990 to $69.5 million inthe same period this year. Net income from continuing operationsfor the quarter rose 16%, from $4.3 million in 1990 to $5 millionin 1991.
Westmark International's net income for the second quarterof 1991 (also end-June) was halved from $5.3 million in 1990 to$2.2 million. Overall revenues declined 10.5% from $126 millionin the second quarter of 1990 to $114.2 million in the same periodof this year. Spacelabs, Westmark's patient monitoring company,had an 11% growth in revenue, while sales at ultrasound subsidiaryATL dipped 23%.
The decline in ATL's ultrasound business resulted from shipmentof non-revenue units during the introduction of its high-definitionimaging (HDI) upgrade to the Ultramark 9 scanner, an increasein backlog for the UM9, and a drop in shipments of low- and mid-tiersystems, Westmark said.
The picture was brighter for Acuson. The dedicated high-endultrasound vendor saw both net sales and net income rise 18% duringthe same quarter. Sales rose to $82.7 million from $70.2 millionin the second quarter of 1990. Net income jumped from $11.8 millionin the second quarter of last year to $14.4 million during thesame period of 1991.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.